Remove Communication Remove Compounding Remove Pharmaceutical Companies
article thumbnail

The digital transformation of pharma’s physician engagement strategies

pharmaphorum

The pandemic has ushered in a number of major changes to healthcare systems, notably in the ways in which pharmaceutical companies communicate, visit and engage with physicians. The threat of disease spread and other risk factors from COVID-19 have only compounded this.

article thumbnail

Merck attempts to reduce levels of carcinogenic compounds in diabetes drugs

Pharmafile

Pharmaceutical company Merck has announced that it is attempting to reduce levels of a cancer-causing compound which has been found in its popular type 2 diabetes drugs. The compound, known as nitrosamines or NTTP, often emerges from chemical reactions that can take place throughout the manufacturing process.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Digital strategies for pharma’s physician engagement

pharmaphorum

Just as the wider healthcare system continues to acclimate to a new normal, the way pharma and physicians communicate is experiencing a technological revolution. Physician access issues coupled with message delivery disconnects only compounded the problem. Inefficient communications pre-COVID.

article thumbnail

Adapting Customer Engagement Strategies to the COVID Landscape

Pharma Marketing Network

In office/in person sales promotion, the staple of pharmaceutical company activities, is simply not possible today with interactions reduced to the sporadic video or to telephone engagement. Understanding how to modify communication style is a first step.

article thumbnail

Patient Engagement in Pharma – Why and How?

Viseven

In an era where medicine is rapidly becoming more personalized, why do pharmaceutical companies still struggle to effectively engage with the very individuals they aim to serve? Additionally, the COVID-19 pandemic has intensified public scrutiny of pharmaceutical companies, creating a unique opportunity to build trust with patients.

article thumbnail

Connected customer data: a golden opportunity for pharma marketers

pharmaphorum

Approximately 30% of global data volume is generated by the healthcare industry and it will continue to expand with a compound annual growth rate predicted to reach 36% by 2025, according to research by RBC Capital Markets. It flows from every direction in torrents to create huge opportunities to address the world’s mounting health issues.

article thumbnail

Influence of 5G on Healthcare

Viseven

As this trend unfolds, it is vital to understand the benefits 5G brings, how it impacts healthcare communication , and how healthcare businesses can leverage it. 5G represents the 5th generation of cellular technology and is the gold standard in wireless communication today. In this article, we will explore these opportunities.